NewAmsterdam Pharma (NAMS) earnings, Jun 30, 2026: EPS −205%, stock +0.1%
In brief
NewAmsterdam Pharma reported on Jun 30, 2026. Earnings per share changed −205% year over year, 3.6% below the estimate; revenue −81%. The stock opened with a +2.1% gap and closed the day +0.1% (Jun 30, 2026). The stock is now 55.2% below its 52-week high, −50.5% over 12 months. Next report: Mar 3, 2027.
EPS vs estimate−3.6%
EPS, YoY−205%
Revenue, YoY−81%
Gap · day+2.1% · +0.1%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| Jun 30, 2026 | +2.1% | +0.1% |
Next-quarter estimates, ratings and the NAMS chart are in the terminal.
Open the terminalFAQ
When is NewAmsterdam Pharma's next earnings report?
Mar 3, 2027. The date comes from daily data and is corrected if the company moves it.
How did NewAmsterdam Pharma stock react to the report?
Opening gap +2.1%, day's result +0.1%.
Did NewAmsterdam Pharma's earnings grow?
Earnings per share fell 205% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.